AtopyNCT00444327
Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy
An observational study of Atopy and Allergic Disease, run by Min-Sheng General Hospital at 2 sites in Taiwan.
Trial summary
The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines. Read more about this study
- Who is it for?
- Ages Up to 1 minuteHealthy volunteers can take part
- Conditions the study is for
- Atopy, Allergic Disease
- How many people
- 900 participants
- Where
- 2 sitesTaiwan
- Study dates
- Mar 2007to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 1 minute
- All sexes
- Healthy volunteers accepted
- Child
Study population: hospital and primary care clinic based study
Who may be able to join
- Apgar score of 5 minutes not less than 7 gestational age not less than 36 weeks
Who cannot join
- Apgar score of 5 minutes < 7 gestational age < 36 weeks
Trial locations and contacts
2 sites in 1 country.
Taiwan2 sites, 2 recruiting
- Not yet recruiting
Min-Sheng General Hospital
Taoyuan
Chien-Han Chen, M.D.
- Recruiting
Min-Sheng General Hospital
Taoyuan
About this study
Official title: Observational Study of Cord Blood Single Nucleotide Polymorphisms of Genes Related to Atopy and Allergic Diseases
The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines. After that, in the prospective follow-up visits, we liked to investigate if the measurement of cord blood SNPs of genes related to atopy and allergic diseases was helpful in predicting the development of atopy and allergic diseases later in life.
- Conditions
- Atopy, Allergic Disease
- Keywords
- single nucleotide polymorphism
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Mar 2007 (estimated)
- Study startMar 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AtopyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 900 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Min-Sheng General Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- National Taiwan University Hospital
- Investigators
- Chien-Han Chen, M.D., Principal investigator, Min-Sheng General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00444327
- Sponsor's protocol ID
- 2007005
- Status last verified
- May 2009
- First submitted
- 6 Mar 2007
- Last updated
- 14 May 2009
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Study of Cord Blood Single Nucleotide Polymorphisms of Genes Related to Atopy and Allergic Diseases
- ClinicalTrials.gov ID
- NCT00444327
- Acronym / sponsor ID
- 2007005
- Conditions
- Atopy, Allergic Disease
- Keywords
- single nucleotide polymorphism
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 900 participants (estimated)
- Lead sponsor
- Min-Sheng General HospitalUniversity, hospital or other
- Collaborators
- National Taiwan University Hospital
- Study start
- Mar 2007
- First posted
- 7 Mar 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines. After that, in the prospective follow-up visits, we liked to investigate if the measurement of cord blood SNPs of genes related to atopy and allergic diseases was helpful in predicting the development of atopy and allergic diseases later in life.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- Up to 1 minute
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- hospital and primary care clinic based study
Key inclusion criteria (1 listed)
- Apgar score of 5 minutes not less than 7 gestational age not less than 36 weeks
Key exclusion criteria (1 listed)
- Apgar score of 5 minutes < 7 gestational age < 36 weeks
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2009.
Related trials for Atopy
RecruitingPhase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Active, not recruitingPhase 2
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Dermatitis, Atopic
RecruitingObservational study
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Eczema, Atopic Dermatitis
RecruitingPhase 2
A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis
Dermatitis Atopic
Active, not recruitingPhase 2
A Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chien-Han Chen, M.D. principal investigator
Min-Sheng General Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Atopy and Allergic Disease, run by Min-Sheng General Hospital at 2 sites in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 May 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Chien-Han Chen, M.D. (886-3-3179599 ext. 2007, chinsword@yahoo.com.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2009.